Clinical Trials Browser

Phase 2/3 × Fingolimod Hydrochloride × Clear all

NCT02939079 2019-05-14

Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients

Phase 2/3 Completed

50 enrolled 20 charts

Multiple Sclerosis